<PAGE> 1
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. )
Filed by the Registrant /X/
Filed by a Party other than the Registrant / /
Check the appropriate box:
<TABLE>
<S> <C>
/ / Preliminary Proxy Statement / / Confidential, for Use of the Commission
Only (as permitted by Rule 14a-6(e)(2))
/X/ Definitive Proxy Statement
/ / Definitive Additional Materials
/ / Soliciting Material Pursuant to sec.240.14a-11(c) or sec.240.14a-12
</TABLE>
CAMBREX CORPORATION
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
/X/ $125 per Exchange Act Rules 0-11(c)(1)(ii), or 14a-6(i)(1), or 14a-6(i)(2)
or Item 22(a)(2) of Schedule 14A.
/ / $500 per each party to the controversy pursuant to Exchange Act Rule
14a-6(i)(3).
/ / Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined):
------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
------------------------------------------------------------------------
(5) Total fee paid:
------------------------------------------------------------------------
/ / Fee paid previously with preliminary materials.
/ / Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
------------------------------------------------------------------------
(3) Filing Party:
------------------------------------------------------------------------
(4) Date Filed:
------------------------------------------------------------------------
<PAGE> 2
CAMBREX CORPORATION
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD APRIL 27, 1995
Notice Is Hereby Given that the 1995 Annual Meeting of Stockholders of
Cambrex Corporation (the "Company") will be held at The Plaza Hotel, Fifth
Avenue at Central Park South, New York, New York on April 27, 1995, at 4:00
P.M., for the following purposes:
1. to elect three (3) directors in Class II to hold office until the
1998 Annual Meeting of Stockholders and until their successors shall be
elected and qualified; and
2. to consider and act upon the approval of the appointment of Coopers
& Lybrand, L.L.P. as independent accountants for 1995; and
3. to transact such other business as may properly come before the
meeting or any adjournment thereof.
Only stockholders of record of Common Stock of the Company at the close of
business on March 15, 1995, will be entitled to vote at the meeting. The list of
such stockholders will be available for inspection by stockholders during the
ten days prior to the meeting in accordance with Section 219 of the Delaware
General Corporation Law at the offices of American Stock Transfer, 6201 15th
Avenue, Brooklyn, New York 11219. Shareholders may make arrangements for such
inspection by contacting Peter E. Thauer, Vice President, General Counsel &
Secretary, Cambrex Corporation, One Meadowlands Plaza, East Rutherford, New
Jersey 07073.
By order of the Board of Directors,
PETER E. THAUER,
Secretary
March 23, 1995
THE VOTE OF EACH STOCKHOLDER IS IMPORTANT.
PLEASE DATE AND SIGN THE ACCOMPANYING PROXY CARD AND PROMPTLY
RETURN IT IN THE POSTAGE PAID ENVELOPE PROVIDED.
<PAGE> 3
CAMBREX CORPORATION
------------------------
1995 ANNUAL MEETING OF
STOCKHOLDERS
PROXY STATEMENT
------------------------
PROXY SOLICITATION
This Proxy Statement is furnished in connection with the solicitation of
proxies by the Board of Directors of Cambrex Corporation (the "Company") for use
at the 1995 Annual Meeting of Stockholders to be held on April 27, 1995, and at
any adjournment of the meeting. The address of the Company's principal executive
office is One Meadowlands Plaza, East Rutherford, New Jersey 07073. This Proxy
Statement and the form of proxy are being mailed to stockholders on or about
March 23, 1995.
The costs of soliciting proxies will be borne by the Company. Brokerage
houses, banks, custodians, nominees and fiduciaries are being requested to
forward the proxy material to beneficial owners, and their reasonable expenses
therefore will be reimbursed by the Company. Solicitation will be made by mail
and also may be made personally or by telephone or telegraph by the Company's
officers, directors and employees without special compensation for such
activities.
REVOCABILITY AND VOTING OF PROXY
A proxy given by a stockholder may be revoked at any time before it is
exercised by giving another proxy bearing a later date or by notifying the
Company in writing of such revocation or by a vote in person at the Annual
Meeting. Properly executed proxies received by the Company will be voted in
accordance with the instructions indicated thereon and if no instructions are
indicated, will be voted for the election of the three nominees for director
named herein, and in favor of the selection of Coopers & Lybrand, L.L.P. as
independent accountants for the Company. The Company knows of no reason why any
of the nominees named herein would be unable to serve for the terms indicated.
In the event, however, that any such nominee should, prior to the election,
become unable to serve as a director, the proxy will be voted for such
substitute nominee, if any, as the Board of Directors shall propose.
The Board of Directors knows of no matters to be presented at the meeting
other than those set forth in the foregoing Notice of Annual Meeting. If other
matters properly come before the meeting, the persons named in the accompanying
form of proxy intend to vote the shares subject to such proxies in accordance
with their best judgment.
RECORD DATE AND VOTING RIGHTS
The Company has only one class of voting securities, Common Stock, par
value $0.10 ("Common Stock"). Only holders of Common Stock of the Company of
record at the close of business on March 15, 1995, will be entitled to vote at
the meeting. On such record date there were outstanding and entitled to vote
5,479,963 shares of Common Stock and each such share is entitled to one vote.
<PAGE> 4
PRINCIPAL STOCKHOLDERS
The following sets forth information with respect to the only persons of
which the Company is aware as of February 10, 1995, who may be deemed to
beneficially own more than 5% of the outstanding Common Stock of the Company:
<TABLE>
<CAPTION>
NUMBER OF SHARES PERCENT
NAME AND ADDRESS BENEFICIALLY OWNED(1) OF CLASS(2)
------------------------------------------------------ --------------------- -----------
<S> <C> <C>
Cyril C. Baldwin, Jr.................................. 481,693 (3) 8.87 %
One Meadowlands Plaza
East Rutherford, New Jersey 07073
Ira Sochet............................................ 480,000 8.84 %
5701 Sunset Drive
Suite 315
South Miami, Florida 33143
Pioneer Management Corp............................... 457,600 (4) 8.42 %
60 State Street
19th Floor
Boston, Massachusetts 02109
FMR Corp.............................................. 434,500 (5) 8.00 %
82 Devonshire Street
Boston, Massachusetts 02109-3614
Wellington Management Company......................... 405,160 (6) 7.46 %
75 State Street
Boston, Massachusetts 02109
The TCW Group, Inc.................................... 380,500 7.01 %
(formerly known as TCW
Management Company)
865 South Figueroa Street
Los Angeles, California 90017
The Guardian Life Insurance........................... 353,800 (7) 6.51 %
Company of America
201 Park Avenue
New York, New York 10020
Arthur I. Mendolia.................................... 312,274 (8) 5.75 %
One Meadowlands Plaza
East Rutherford, New Jersey 07073
</TABLE>
- ---------------
(1) Unless otherwise indicated (a) share ownership is based upon information
furnished as of February 10, 1995, by the beneficial owner, and (b) each
beneficial owner has sole voting and investment power with respect to the
shares shown.
(2) For the purpose of this table, the percent of issued and outstanding shares
of Common Stock of the Company held by each beneficial owner has been
calculated on the basis of (i) 5,423,975 shares of Common Stock issued and
outstanding (excluding treasury shares) on February 10, 1995, (ii) all
shares of Common Stock subject to stock options which are held by such
beneficial owner and are exercisable within 60 days of February 10, 1995,
and (iii) 7,974 shares still to be issued in connection with the 1993
conversion of the Company's 9% Convertible Subordinated Notes.
(3) Includes 196,750 shares issuable under outstanding options under the
Company's Stock Option Plans which options are fully exercisable, and 53,559
shares held at December 31, 1994, in the Company's Savings Plan.
(4) In an amendment to Schedule 13G under the Securities Exchange Act of 1934
dated January 18, 1995, and filed by Pioneer Management Corporation
("Pioneer"), Pioneer reported that it has the sole voting
2
<PAGE> 5
power for 457,600 shares, and shares dispositive power for 429,900 shares.
Pioneer also has sole dispositive power for 27,700 of the shares.
(5) In an amendment to Schedule 13G under the Securities Exchange Act of 1934
dated February 13, 1995, and filed by FMR Corp., FMR Corp. reported that
Fidelity Management & Research Company ("Fidelity"), an investment advisor
and wholly-owned subsidiary of FMR Corp., is the beneficial owner of 434,500
shares. Edward C. Johnson 3d and Abigail P. Johnson, (reported to own 24.9%
of FMR Corp.), FMR Corp., (through its control of Fidelity), and the
Fidelity Contrafund, (an investment company advised by Fidelity), share
power to dispose of the 434,500 shares. Neither FMR Corp. nor Edward C.
Johnson 3d, its Chairman, has the power to vote or direct the voting of the
shares owned directly by the Fidelity Contrafund, which power resides with
the Contrafund's Board of Trustees.
(6) In an amendment to Schedule 13G under the Securities Exchange Act of 1934
dated January 24, 1995, filed by Wellington Management Company ("WMC"), WMC
reported that by reason of advisory relationships with numerous investment
counselling clients, WMC may be deemed to be the beneficial owner of 405,160
shares. WMC shares power to dispose of all shares and shares voting power as
to 262,200 shares with its investment counselling clients.
(7) In a Schedule 13G under the Securities Exchange Act of 1934 dated February
13, 1991 and filed by The Guardian Life Insurance Company of America
("Guardian Life"), Guardian Life reported that it has sole power to vote and
dispose of 130,000 of the shares, and shares voting and dispositive power
for 52,000 of the shares. Guardian Life's wholly owned subsidiary, Guardian
Investor Services Corporation, shares both dispositive and voting power for
171,800 shares by reason of advisory services provided to affiliated mutual
funds.
(8) The number of shares reported includes 1,000 shares issuable upon exercise
of options granted under the Company's 1994 Stock Option Plan and 11,624
shares held at December 31, 1994, in the Company's Savings Plan.
3
<PAGE> 6
COMMON STOCK OWNERSHIP BY DIRECTORS AND EXECUTIVE OFFICERS
The following table gives information concerning the beneficial ownership
of the Company's Common Stock on February 10, 1995, by (i) each director and
nominee for election as a director, (ii) each of the executive officers named in
the Summary Compensation Table (below) and (iii) all directors and executive
officers of the Company as a group.
<TABLE>
<CAPTION>
SHARES
BENEFICIALLY PERCENT OF
BENEFICIAL OWNERS OWNED(1) CLASS(2)
------------------------------------------------------- ------------ ----------
<S> <C> <C>
Cyril C. Baldwin, Jr. ................................. 481,693(3) 8.87%
Rosina B. Dixon, M.D. ................................. 0 *
Francis X. Dwyer....................................... 10,000(4) *
George J.W. Goodman.................................... 2,872(4) *
Kathryn Rudie Harrigan................................. 1,000 *
Leon J. Hendrix, Jr.................................... 0 *
Ilan Kaufthal.......................................... 5,032(4) *
Robert W. Lear......................................... 10,688(4) *
Robert LeBuhn.......................................... 6,432(4) *
James A. Mack.......................................... 125,345(5) 2.31%
Arthur I. Mendolia..................................... 312,274(6) 5.75%
Dean P. Phypers........................................ 7,500(4) *
Albert L. Eilender..................................... 65,096(7) 1.20%
Peter Tracey........................................... 61,638(8) 1.14%
Peter E. Thauer........................................ 49,578(9) *
All Directors and Executive Officers as
a group (27 persons)................................. 1,288,377(10) 23.72%
</TABLE>
- ---------------
* Beneficial Ownership is less than 1% of the Common Stock outstanding.
(1) Except as otherwise noted, reported share ownership is as of February 10,
1995. Unless otherwise stated, each person has sole voting and investment
power with respect to the shares of Common Stock he beneficially owns.
(2) For the purpose of this table, the percent of issued and outstanding shares
of Common Stock of the Company held by each beneficial owner has been
calculated on the basis of (i) 5,423,975 shares of Common Stock issued and
outstanding (excluding treasury shares) on February 10, 1995, (ii) all
shares of Common Stock subject to stock options which are held by such
beneficial owner and are exercisable within 60 days of February 10, 1995,
and (iii) 7,974 shares still to be issued in connection with the 1993
conversion of the Company's 9% Convertible Subordinated Notes.
(3) The number of shares reported includes 196,750 shares issuable upon
exercise of options granted under the Company's Stock Option Plans and
53,559 shares held at December 31, 1994, in the Company's Savings Plan.
(4) The number of shares reported includes 1,000 shares issuable upon exercise
of options granted under the Company's 1994 Stock Option Plan.
(5) The number of shares reported includes 70,000 shares issuable upon exercise
of options granted under the Company's Stock Option Plans and 11,160 shares
held at December 31, 1994, in the Company's Savings Plan. 1205 shares held
by several family members are not included and beneficial ownership of such
shares is disclaimed.
(6) The number of shares reported includes 1,000 shares issuable upon exercise
of options granted under the Company's 1994 Stock Option Plan and 11,624
shares held at December 31, 1994, in the Company's Savings Plan.
4
<PAGE> 7
(7) The number of shares reported includes 10,096 shares held at December 31,
1994, in the Company's Savings Plan. 550 shares held by family members are
not included and beneficial ownership of such shares is disclaimed.
(8) The number of shares reported includes 30,000 shares issuable upon exercise
of options granted under the Company's Stock Option Plans and 3238 shares
held at December 31, 1994, in the Company's Savings Plan.
(9) The number of shares reported includes 35,000 shares issuable upon exercise
of options granted under the Company's Stock Option Plans and 6778 shares
held at December 31, 1994, in the Company's Savings Plan.
(10) The number of shares reported includes 271,000 shares issuable upon
exercise of options that become exercisable within 60 days and 40,213
shares held at December 31, 1994, in the Company's Savings Plan. Shares
held by immediate family members are not included and beneficial ownership
of such shares is disclaimed.
BOARD OF DIRECTORS
The Board of Directors is responsible for directing the management of the
business and affairs of the Company. The Board holds regular meetings five times
each year and holds additional special meetings as required. During 1994 the
Board held nine meetings.
The Board has established four standing committees, the Audit Committee,
the Compensation Committee (formerly the Organization and Compensation
Committee), the Environmental Committee and the Governance Committee (formerly
the Nominating Committee).
The Audit Committee, comprised of six non-employee directors, recommends to
the Board the accounting firm to act as the independent accountants for the
Company, consults with the accounting firm concerning the scope of the audit,
reviews the audit results and reviews the Company's internal financial controls
and procedures with the accountants and with members of management. The Audit
Committee held four meetings in 1994.
The Compensation Committee, comprised of five non-employee directors,
oversees the Company's executive compensation programs and policies and
administers the Company's Stock Option and Long-term Incentive Plans. The
Compensation Committee held five meetings in 1994.
The Environmental Committee, comprised of eight non-employee directors,
oversees the Company's environmental affairs. The Environmental Committee held
four meetings during 1994.
The Governance Committee, comprised of three non-employee directors, makes
recommendations to the Board of Directors concerning nominees for election to
the Board at Annual Meetings and candidates for newly created directorships and
vacancies on the Board. The Governance Committee will consider nominees
recommended by stockholders. Such recommendations for the 1996 Annual Meeting
should be sent to the Corporate Secretary of the Company not later than January
14, 1996, and should include a statement of the nominee's qualifications. The
Governance Committee held one meeting in 1994.
Under the retirement policy for non-employee directors established by the
Board of Directors in 1989, a non-employee director (other than incumbent
directors when the policy was adopted) must not have attained age 72 at the time
of election and may not serve as a director beyond the Annual Meeting next
following such person's 72nd birthday.
COMPENSATION OF DIRECTORS
The Company pays each non-employee director of the Company an annual fee of
$12,000 and $600 for each Board, Committee (other than the Environmental
Committee) and Stockholders meeting attended, except that the Chairmen of the
Compensation, Audit and Governance Committees receive $900 for each Committee
meeting attended. The Chairman of the Environmental Committee receives $900 for
each
5
<PAGE> 8
Environmental Committee meeting attended, but the remaining Committee members do
not receive fees for meeting attendance. Directors also receive reimbursement
for expenses incurred in connection with attendance. Employees of the Company
who are directors are not paid any separate fees for acting as directors.
In October 1993 the Board of Directors adopted the 1994 Stock Option Plan
(the "1994 Plan") which was approved by shareholders at the 1994 Annual Meeting
of Stockholders. Pursuant to the terms of the Non-Employee Director Program of
the 1994 Plan, each individual who was a non-employee director on October 28,
1993 was awarded a grant of options to purchase 1,000 shares of the Company's
Common Stock. The 1994 Plan further provides that beginning after the 1995
Annual Meeting each non-employee director will receive a grant of options to
purchase 500 shares of the Company's Common Stock at the first meeting of the
Board of Directors following each Annual Meeting of Stockholders of the Company.
In October 1993, the Board of Directors granted options to purchase 1,000 shares
of Common Stock under the 1994 Stock Option Plan to each of Francis X. Dwyer,
George J.W. Goodman, Kathryn Rudie Harrigan, Ilan Kaufthal, Robert W. Lear,
Robert LeBuhn and Dean P. Phypers.
DIRECTORS' RETIREMENT PLAN
Non-employee directors of the Company participate in a non-qualified,
noncontributory pension plan, which provides for the payment after retirement
from the Board of an annual amount equal to the Board retainer at the time of
retirement. Members must have at least five years of service on the Board prior
to retirement to receive a benefit. The duration of this payment equals the
number of years of Board service (to a maximum of ten) calculated starting with
1993.
As of December 31, 1994, the years of service for the participating
directors are as follows: Francis X. Dwyer -- 2 years; George J.W. Goodman -- 2
years; Kathryn Rudie Harrigan -- 1 year; Ilan Kaufthal -- 2 years; Robert W.
Lear -- 2 years; Robert LeBuhn -- 2 years; Dean P. Phypers -- 2 years.
ELECTION OF DIRECTORS
The Board of Directors of the Company is divided into three classes. The
term of office of the directors in Class II expires at this Annual Meeting with
the terms of office of the directors in Class III and Class I ending at
successive Annual Meetings. At this Annual Meeting three directors in Class II
will be elected to hold office until the 1998 Annual Meeting and until their
successors shall be elected and qualified. To be elected, each nominee for
director requires a majority of the votes cast. Abstentions from voting (but not
including broker non-votes) will have the effect of votes against the nominees.
The following sets forth with respect to the three persons who have been
nominated by the Board of Directors for election at this Annual Meeting and the
other directors of the Company certain information concerning their positions
with the Company (including its predecessor and now wholly-owned subsidiary
CasChem, Inc.) and principal outside occupations, and other directorships held.
Mr. Robert Lear and Mr. Arthur Mendolia, current directors of the Company, are
retiring from the Board at the 1995 Annual Meeting.
NOMINEES FOR ELECTION TO SERVE AS DIRECTORS UNTIL 1998 ANNUAL MEETING (CLASS II)
Rosina B. Dixon, M.D. (age 52). Dr. Dixon has been a consultant to the
pharmaceutical industry since May 1986. Prior to that time, she was Vice
President and Secretary of Medical Market Specialties Incorporated, as well as a
member of its Board of Directors. Dr. Dixon previously served as Medical
Director, Schering Laboratories, Schering-Plough Corporation. Prior to that, she
was Executive Director Biodevelopment, Pharmaceuticals Division, CIBA-GEIGY
Corporation. She is a member of the Boards of Directors of Church & Dwight Co.,
Inc. and Enzon, Inc.
Leon J. Hendrix, Jr. (age 51). Principal of Clayton, Dubilier & Rice,
Inc., a private investment firm, since November 1994. Prior thereto, Mr. Hendrix
was with Reliance Electric Company, a manufacturer and seller of industrial and
telecommunications equipment and services, since 1973, where he held a series of
executive level positions, most recently Chief Operating Officer and a member of
the Board of Directors since 1992. Mr. Hendrix is a member of the Boards of
Directors of Keithley Instruments, Inc., National City Bank
6
<PAGE> 9
of Cleveland, Allison Engine Co., Wesco Distribution, Inc., and Remington Arms
Co. He is also a member of the Clemson University Foundation Board of Directors
and previously served on the Board of Governors of the National Electrical
Manufacturers Association and the Board of Directors of the Cleveland Chapter of
the American Red Cross.
Ilan Kaufthal (age 47). Director since the Company commenced business in
1981. Chairman of the Audit Committee and member of the Environmental Committee
of the Board of Directors. A Managing Director of the investment firm of
Wertheim Schroder & Co., Incorporated since 1987. Prior to 1987 held various
executive positions with NL Industries, Inc., a firm in the chemicals and
petroleum services businesses, most recently Senior Vice President and Chief
Financial Officer since 1983. Director of Rexene Corporation and United Retail
Group, Inc.
DIRECTORS SERVING UNTIL 1996 ANNUAL MEETING (CLASS III)
Francis X. Dwyer (age 69). Director since 1989. Chairman of the
Environmental Committee and member of the Compensation Committee of the Board of
Directors. President of Nuodex Inc., a chemical manufacturer, since its
formation in 1982 until its acquisition by Huls AG of West Germany in 1985.
Thereafter, Chairman of the Board of Huls America Inc., a chemical manufacturer,
until May 1991. Since May 1991, Chairman of International Dioxide, Inc., a
chemical manufacturer.
James A. Mack (age 57). Director, President and Chief Operating Officer
since joining the Company in February 1990. On January 26, 1995 elected Chief
Executive Officer of the Company, effective April 1, 1995. Prior to joining the
Company, with Olin Corporation, a manufacturer of chemical and other products
since 1984 as Vice President, Specialty Chemicals and, more recently, Vice
President, Performance Chemicals. Executive Vice President of Oakite Products,
Inc. from 1982 to 1984. Prior to joining Oakite held various positions with The
Sherwin-Williams Company, most recently as President and General Manager of the
Chemicals Division from 1977 to 1981. Past Chairman of the Board of Governors of
the Synthetic Organic Chemical Manufacturing Association and Member of the Board
of Trustees of the Michigan Tech Alumni Fund.
Dean P. Phypers (age 66). Director since 1988. Member of the Audit,
Compensation, Environmental and Governance Committees of the Board of Directors.
Retired as Senior Vice President and director of International Business Machines
Corporation in February 1987 after 32 years in various positions with that
corporation including Chief Financial Officer, member of the Management
Committee, Corporate Office contact for international operations and head of the
Corporate Operations Staff. Director of American International Group Inc.,
Bethlehem Steel Corporation and Church & Dwight Co., Inc.
DIRECTORS SERVING UNTIL 1997 ANNUAL MEETING (CLASS I)
Cyril C. Baldwin, Jr. (age 67). Director and President (until early 1990)
since the Company commenced business in 1981. Mr. Baldwin has been Chief
Executive Officer since 1984. He will retire from that position, effective April
1, 1995 and from the Company, effective April 30, 1995. Mr. Baldwin will
continue thereafter as Chairman of the Board, a position he has held since his
election in 1991. Director of Church & Dwight Co., Inc. and Congoleum
Corporation.
George J. W. Goodman (age 64). Director since the Company commenced
business in 1981. Member of the Compensation and Environmental Committees of the
Board of Directors. Since 1971 has been the President of Continental Fidelity,
Inc., an editorial consulting services and products firm. Director of USAir
Group, Inc. and Trustee of The Urban Institute.
Kathryn Rudie Harrigan (age 44). Director since 1994. Member of the Audit
and Environmental Committees. Since 1981, Professor, Management of Organizations
Division of the Columbia University Business School, since 1994, Faculty
Director, Chazen Institute for International Business at the Columbia University
Business School and, since 1993, the Henry R. Kravis Professor of Business
Leadership at the Columbia University Business School. Member of the Advisory
Board of Ronin Development since 1988, and External Member, Strategic Planning
Committee of the Panasonic Industrial Controls Division, Matsushita
7
<PAGE> 10
Corporation from 1989 to 1992. Member of the Board of Governors, Academy of
Management from 1986 to 1988.
Robert LeBuhn (age 62). Director since the Company commenced business in
1981. Chairman of the Governance Committee and member of the Audit,
Compensation, and Environmental Committees of the Board of Directors. Retired
Chairman, Investor International (U.S.), Inc., a private investment firm. Mr.
LeBuhn was President from 1984 to 1993, and Chairman until October 1994.
Director of USAir Group, Inc., Acceptance Insurance Companies, Inc., Lomas
Financial Corp., Amdura Corp. and Enzon, Corp.
During 1994, each incumbent director attended more than 75% of the
aggregate of the meetings of the Board and Committees of the Board of which such
director was a member.
RELATED PARTY TRANSACTIONS
Mr. Kaufthal is a Managing Director of Wertheim Schroder & Co., who provide
the Company from time to time with investment advisory services.
COMPENSATION COMMITTEE REPORT
ON EXECUTIVE COMPENSATION
COMPENSATION PHILOSOPHY
Cambrex seeks to be a leading specialty chemicals company, providing
superior return to its owners. To achieve this, the Company plans to be among
the top quartile of its peers within the industry. To meet these objectives, the
Company must be able to attract, motivate and retain personnel with the
requisite skills and abilities to enable the Company to achieve superior
operating results. Accordingly, the Company's compensation programs are designed
to reward above average performance and provide incentive opportunity to be
competitive in the labor markets in which the Company participates.
EXECUTIVE COMPENSATION
The Company's executive compensation administration program involves two
components. Annual compensation is in the form of base salary plus a yearly
incentive award. Long-term compensation consists of stock options, which are
intended to reward executives when improvements in operating performance
increase the market value of the Company for its shareholders.
The accomplishment of results measured against the executives' goals and
objectives are reviewed by the Compensation Committee subsequent to review and
recommendation from the Office of the Chairman. Executives are rewarded for
results achieved that contribute to key operating results; i.e., sales, net
income, return on investment, and other assigned goals including but not limited
to: service and quality improvement, product and marketing development,
technology development, and personnel development. The Company uses independent
salary surveys of its Peer Group and a broader range of specialty chemical
companies to assist in determining appropriate levels of compensation for each
executive position. The Company targets annual executive compensation at the
median levels in companies surveyed.
Annual incentive compensation awards are based on corporate performance and
individual performance. The size of the overall incentive compensation pool is
determined by the total net income generated and by the incremental increase in
net income over the prior year. The achievement of personal objectives
determines individual awards which are paid out as a portion of the total
incentive compensation pool. The incentive plan provides a better than average
individual award when net income substantially exceeds prior year's earnings.
Long-term compensation for executives is in the form of Company stock
option grants, which are awarded based on an individual's position in the
Company, the individual's performance, and the number of outstanding option
awards. Two types of stock options are granted to the executive group. The first
type are regular Incentive Stock Options or Non-Qualified Options. The second
type of options are available to the Company's most Senior Executives, including
those individuals named in the Summary Compensation Table (below). These options
become exercisable if the publicly traded share price of the Company's shares
exceeds predetermined levels for designated periods of time. Under the 1989
Senior Executive Option Plan, one-third of the grants to senior executives
became subject to exercise when the Company's publicly traded Common Stock price
equalled or exceeded an average of $14 or above for 20 consecutive trading days
commencing
8
<PAGE> 11
within one year from the date of grant. Similarly, a second one-third became
exercisable when the traded share price equalled or exceeded an average of $17
for 20 consecutive trading days commencing during the second option year. On
February 1, 1994, the final one-third of the options became exercisable, as the
Company's publicly traded share price exceeded an average of $21 for 20
consecutive trading days. On April 28, 1994, shareholders approved the 1993
Senior Executive Stock Option Plan (the "1993 Plan") and certain awards
thereunder. The 1993 Plan provides that one-third of the approved grants to
senior executives shall become subject to exercise if the Company's publicly
traded common stock price equals or exceeds an average of $30 or above for 20
consecutive trading days prior to October 28, 1994. Similarly, a second one-
third, and any of the first one-third of the approved grant awards not otherwise
exercisable, shall become exercisable if the traded share price equals or
exceeds an average of $35 per share for 20 consecutive trading days prior to
October 28, 1995. The final one-third of the option awards, and any option
awards not otherwise exercisable, shall become exercisable if the traded share
price equals or exceeds an average price of $40 per share for 20 consecutive
trading days during the remaining life of the option.
CHIEF EXECUTIVE OFFICER COMPENSATION
Mr. Baldwin, the Company's Chief Executive Officer, received $300,000 in
annual compensation in 1994. His compensation was determined based upon the same
factors used in setting other executive compensation.
Mr. Baldwin received an incentive compensation award for fiscal 1994 of
$260,000. This award reflects Mr. Baldwin's success in the pursuit of strategic
acquisitions and the substantial improvement in financial performance achieved
by the Company, as net income was increased from $8,641,000 in 1993 to more than
$11,100,000 in 1994, and total shareholder return increased by more than 28%.
The total market value of the Company's shares increased by nearly $31,500,000
in 1994. Mr. Baldwin's annual compensation was directly related to the
improvement in both earnings and shareholder value in 1994 and the continued
international growth of the Company.
Mr. Baldwin was not awarded any stock options under the 1993 Plan due to
his pending retirement and his own recommendation to the Compensation Committee.
This recommendation was based upon the number of stock option awards received by
him in prior years and his current level of stock ownership in the Company.
On January 26, 1995, Mr. Baldwin announced his retirement as Chief
Executive Officer, effective April 1, 1995, and from the Company, effective
April 30, 1995. Mr. Baldwin will remain Chairman of the Board. Mr. Mack has been
elected Chief Executive Officer effective April 1, 1995. Mr. Mack's 1995
compensation will be at an annual rate of $300,000.
POLICY REGARDING SECTION 162(M)
Based on current levels of base salary and annual bonuses, the Compensation
Committee believes that it is highly unlikely that the Company will pay
compensation to any of its executive officers for 1995 services in excess of one
million dollars. Thus, the Compensation Committee has recommended no adjustment
with respect to 1995 cash compensation in light of the limitation on
deductibility of compensation in excess of one million dollars under Section
162(m) of the Internal Revenue Code. However, the 1993 Senior Executive Stock
Option Plan and the 1994 Stock Option Plan were designed and stockholder
approval was obtained at the 1994 Annual Meeting in order that options granted
thereunder would be exempt from the limitations contained in Section 162(m) of
the Internal Revenue Code.
COMPENSATION COMMITTEE
Robert W. Lear, Chairman
Francis X. Dwyer
George J.W. Goodman
Robert LeBuhn
Dean P. Phypers
9
<PAGE> 12
The following table summarizes the compensation paid to the Chief Executive
Officer and each of the four highest paid executive officers (the "Named
Executive Officers") during the previous three fiscal years for services in such
capacities to the Company and its subsidiaries.
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
ANNUAL COMPENSATION LONG TERM COMPENSATION
-------------------------------- ----------------------------------
OTHER SECURITIES ALL
ANNUAL RESTRICTED UNDER- PAYOUTS- OTHER
COMPEN- STOCK LYING LTIP COMPEN-
SATION AWARD(S) OPTION/ PAYOUTS SATION
NAME AND PRINCIPAL POSITION YEAR SALARY ($) BONUS ($) ($)(1) ($) SARS ($) (3) ($)(2)
- ---------------------------------- ---- ---------- --------- ------- ---------- ---------- -------- -------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Cyril C. Baldwin, Jr.............. 1994 300,000 260,000 -0- -0- -0- -0- 6,750
Chairman of the Board 1993 300,000 210,000 -0- -0- -0- -0- 10,612
and Chief Executive Officer 1992 275,000 409,901 -0- -0- -0- -0- 10,298
James A. Mack..................... 1994 265,000 225,000 -0- -0- -0- -0- 6,750
President and Chief 1993 249,984 175,000 -0- -0- 45,000 -0- 10,612
Operating Officer 1992 230,000 342,827 -0- -0- -0- -0- 10,298
Peter Tracey...................... 1994 187,500 200,000 -0- -0- -0- -0- 6,750
Executive Vice President,
Finance 1993 176,665 115,000 -0- -0- 25,000 -0- 8,875
and Chief Financial Officer 1992 166,667 198,740 -0- -0- 10,000 -0- 7,500
Albert L. Eilender................ 1994 205,341 96,000 -0- -0- -0- -0- 6,750
Executive Vice President 1993 205,341 85,000 -0- -0- 25,000 -0- 9,240
1992 205,341 96,472 -0- -0- -0- -0- 9,240
Peter E. Thauer................... 1994 153,125 140,000 -0- -0- -0- -0- 6,750
Vice President -- Law and 1993 144,167 65,000 -0- -0- 30,000 -0- 6,487
Environment, General Counsel 1992 132,533 118,529 -0- -0- -0- -0- 5,964
and Secretary
</TABLE>
- ---------------
(1) The rules require disclosure only when the aggregate value of these items
exceeds the lesser of $50,000 or 10% of salary and bonus.
(2) Amounts indicated are attributable to Company contributions under the
Company's Savings Plan.
No options were granted to the Named Executive Officers in 1994.
The following table sets forth information for each Named Executive Officer
with regard to the aggregate options exercised during 1994 and the aggregate
stock options held as of December 31, 1994.
AGGREGATE OPTION/SAR EXERCISES IN LAST FISCAL YEAR AND
FY-END OPTION/SAR VALUES
<TABLE>
<CAPTION>
NUMBER OF
SECURITIES VALUE OF
UNDERLYING UNEXERCISED
UNEXERCISED IN-THE-MONEY
SHARES OPTIONS/SARS OPTIONS/SARS
ACQUIRED ON VALUE AT FY-END (#) AT FY-END ($)
EXERCISE REALIZED EXERCISABLE/ EXERCISABLE/
NAME (#) ($)(1) UNEXERCISABLE UNEXERCISABLE(2)
- --------------------------------- ----------- -------- ----------------------- -------------
<S> <C> <C> <C> <C>
Cyril C. Baldwin, Jr............. -0- NA 196,750 Exercisable 3,973,856
James A. Mack.................... 5,000 76,900 97,000 Exercisable 1,908,750
45,000 Unexercisable 275,625
Peter Tracey..................... 1,500 22,320 52,800 Exercisable 986,300
25,000 Unexercisable 153,125
Albert L. Eilender............... -0- NA 52,150 Exercisable 1,261,554
25,000 Unexercisable 153,125
Peter E. Thauer.................. 2,200 45,925 37,800 Exercisable 698,625
25,000 Unexercisable 153,125
</TABLE>
- ---------------
(1) Based upon the market value of underlying securities at exercise minus the
exercise price.
(2) Market value of the underlying securities at December 31, 1994 ($26 per
share) minus the exercise price.
10
<PAGE> 13
The following graph compares the Company's cumulative total stockholder
return, for a five year period, with a performance indicator of the overall
stock market and a group of peer issuers. Prices are as of December 31 of the
year indicated.
COMPARISON OF FIVE YEAR CUMULATIVE TOTAL RETURN
AMONG CAMBREX CORPORATION, THE DOW JONES INDUSTRIAL
AVERAGE AND PEER GROUP(1)
<TABLE>
<CAPTION>
MEASUREMENT PERIOD
(FISCAL YEAR COVERED) DOW JONES PEER GROUP CBM
<S> <C> <C> <C>
1989 100 100 100
1990 96 110 35
1991 127 197 73
1992 138 228 143
1993 152 244 172
1994 153 200 223
</TABLE>
- ---------------
(1) Assumes $100 invested on December 31, 1989, with all dividends reinvested.
The Company manufactures and markets a broad line of specialty chemicals,
fine chemicals and commodity chemical intermediates to a diverse group of
customers. Because the Company's products and customers are diverse, the Company
does not believe that there is a single published industry or line of business
index that is appropriate for comparing stockholder return. The Peer Group
selected by the Company for the above Performance Graph is composed of those
companies considered most comparable to the Company in terms of amount of sales,
product lines and customers.
Those companies included in the Peer Group are: Crompton & Knowles
Corporation; The Dexter Corporation; Ferro Corporation; Great Lakes Chemical
Corporation; Lawter International, Inc.; Rohm and Haas Company; Stepan Company;
and Witco Corporation.
RETIREMENT PLANS
Retirement benefits are based on an employee's years of service and the
employee's compensation. "Compensation" for the purposes of the computation of
benefits, includes regular compensation, bonuses and overtime, but excludes
income attributable to fringe benefits and perquisites. The retirement benefit
generally is calculated by multiplying the participant's years of service by 1%
of compensation and by 0.6% of compensation in excess of the participant's
social security covered compensation, and aggregating such
11
<PAGE> 14
amounts, subject to the limitations imposed by the Employee Income Security Act
of 1974 ("ERISA"). Although Final Average Compensation includes the items
mentioned above, the Plan limits the maximum amount of compensation which may be
taken into account for the purposes of calculating benefits to the ERISA limit
for covered compensation, which was $150,000 during 1994. Therefore, any
compensation received by any of the Named Executive Officers which exceeds this
amount will not be taken into account in the calculation of their benefits under
this Plan. A Supplemental Non-Qualified Pension Plan, which became effective on
January 1, 1994, provides benefits based on compensation levels above the ERISA
maximum compensation level.
The following table shows the estimated aggregate annual retirement
benefits payable under the Company's Qualified and Supplemental pension plans to
employees who retire at the normal retirement age at the stated levels of Final
Average Compensation and years of service.
PENSION PLAN TABLE
ESTIMATED ANNUAL RETIREMENT BENEFITS
<TABLE>
<CAPTION>
BASED ON SERVICE OF
FINAL AVERAGE ------------------------------------------------------------
COMPENSATION 15 YEARS 20 YEARS 25 YEARS 30 YEARS 35 YEARS
- ------------------------------------ -------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
$125,000............................ $ 27,829 $ 37,105 $ 46,382 $ 55,659 $ 64,936
$150,000............................ $ 33,829 $ 45,105 $ 56,382 $ 67,659 $ 78,936
$175,000............................ $ 39,829 $ 53,105 $ 66,382 $ 79,659 $ 92,936
$200,000............................ $ 45,829 $ 61,105 $ 76,382 $ 91,659 $106,936
$225,000............................ $ 51,829 $ 69,105 $ 86,382 $103,659 $120,936
$250,000............................ $ 57,829 $ 77,105 $ 96,382 $115,659 $134,936
$300,000............................ $ 69,829 $ 93,105 $116,282 $139,659 $162,936
$400,000............................ $ 93,829 $125,105 $156,382 $187,659 $218,936
$450,000............................ $105,829 $141,105 $176,382 $211,659 $246,936
$500,000............................ $117,829 $157,105 $196,382 $235,659 $274,936
</TABLE>
As of December 31, 1994, the years of service credited for retirement
benefits for the Named Executive Officers are as follows: Cyril C. Baldwin,
Jr. -- 13 years; James A. Mack -- 4 years; Peter Tracey -- 4 years; Albert L.
Eilender -- 5 years; Peter E. Thauer -- 5 years.
DEFERRED COMPENSATION PLAN
The Company has established a Non-qualified Deferred Compensation Plan for
Key Executives (the "Deferred Plan"). Under the Deferred Plan an officer or key
employee may elect to defer all or any portion of their pre-tax annual bonus
and/or annual base salary (other than the minimum required Social Security
contributions and $10,000). The deferred amount is invested in Fidelity Funds
available under the Cambrex Savings Plan, except for the Cambrex Stock Fund. The
Deferred Plan is not funded by the Company, but the Company has established a
Deferred Compensation Trust Fund to protect the account balance in the case of a
change of control of the Company.
CHANGE IN CONTROL ARRANGEMENTS
The Company has entered into agreements with a number of key employees,
including the Named Executive Officers, with the objective of preserving
management stability in the event of a threatened or actual change of control of
the Company. Under each agreement, in the event of a change of control of the
Company (defined in the agreement to include certain events involving changes in
ownership of the Company's stock or the composition of the Company's Board of
Directors or other structural changes, but, in any case, with the Board having
discretion to find other events to constitute a change of control) the employee
is awarded a three-year contract of employment in substantially the same
position he had prior to the start of the
12
<PAGE> 15
employment contract term. The contract of employment is at a monthly salary not
less than the highest monthly salary earned by the employee during the 12 months
preceding the start of the employment contract term and provides for an annual
bonus and benefits comparable to those pertaining to the employee prior to the
start of the employment contract term.
In the event that at any time during the employment contract term the
employee's employment is terminated, (i) by the Company (other than by reason of
disability or for cause), or (ii) by the employee by reason of the Company's
violation of the terms of the employment contract, or (iii) by the employee
during the thirteenth month of the employment contract term, with or without
reason, the employee will be entitled to a lump sum payment in an amount equal
to the sum of (a) a ratable portion of the amount of the highest annual bonus
paid to the employee during the three years prior to the year of termination,
based upon the elapsed time in the year of termination, (b) up to three times
the annual salary under the contract and three times such highest annual bonus,
which amount declines ratably over a 36 month term for each month the employee
remains employed by the Company following the first anniversary of the start of
the employment contract term and (c) the present value of the pension benefit
lost by the employee by reason of the early termination of employment. In the
event of such termination the employee will also be entitled to the employment
benefits, such as health insurance and life insurance, to which he would have
been entitled had his employment not been terminated, and to the immediate right
to exercise any employee stock options notwithstanding their stated
exercisability in installments. Additionally, the employment contracts provide
for an additional payment to the employee to cover any excise tax payable by the
employee on so-called excess golden parachute payments under Section 4999 of the
Internal Revenue Code of 1986, as amended.
MANAGEMENT CONTRACTS
During 1989 the Board of Directors authorized an agreement with Mr.
Mendolia pursuant to which he may, at his election and at any time after January
1, 1990, enter into a consulting arrangement with the Company upon his
resignation as an employee. Pursuant to this agreement Mr. Mendolia is obligated
to provide certain financial, consulting and advisory services to the Company as
determined by the Chief Executive Officer. The contract shall continue for the
remainder of Mr. Mendolia's life at an annual fee of $100,000. Mr. Mendolia
retired as an employee on June 1, 1993, and began receiving payments under the
agreement.
During 1990 the Board of Directors authorized an agreement with Mr. Baldwin
pursuant to which he may, at his election and at any time after January 1, 1994,
enter into a consulting arrangement with the Company upon his resignation as an
employee. Pursuant to this agreement Mr. Baldwin is obligated to provide certain
financial, consulting and advisory services to the Company as determined by the
Chief Executive Officer. The contract continues for the remainder of Mr.
Baldwin's life at an annual fee of $140,000.
In 1994 the Company reached agreement with Mr. Mendolia and Mr. Baldwin to
restate their consulting arrangements. Under the restated arrangements, each of
them entered into two agreements at the prior rates, the first providing for
consulting services while the executive is able to provide such services and the
second providing an additional retirement benefit for the remainder of the
executive's lifetime.
Mr. Baldwin will retire as Chief Executive Officer, effective April 1,
1995, and as an employee of the Company, effective April 30, 1995, and may elect
to begin receiving payments under the agreement at that time.
At a meeting held on January 26, 1995, the Board of Directors authorized
similar agreements with Mr. Mack at an annual rate of $100,000.
APPOINTMENT OF AUDITORS
The Board of Directors, in accordance with the recommendation of the Audit
Committee, has selected Coopers & Lybrand, L.L.P. to be the Company's
independent accountants for 1995, subject to the approval of the stockholders.
13
<PAGE> 16
Coopers & Lybrand, L.L.P. was engaged on March 19, 1992. A representative
of Coopers & Lybrand, L.L.P. is expected to be present at the meeting, will be
afforded an opportunity to make a statement if such representative desires to do
so and is expected to be available to respond to appropriate questions.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE PROPOSAL.
STOCKHOLDER PROPOSALS
Stockholder proposals intended to be presented at the 1996 Annual Meeting
must be received by the Company not later than November 24, 1995, in order to be
included in the Company's Proxy Statement for the 1996 Annual Meeting. In
addition, the Company's by-laws provide that any shareholder wishing to present
a nomination for the office of director before a shareholder meeting for a vote
must give the Company at least 90 days advance notice, any shareholder wishing
to bring a proposal or other business before a shareholder meeting for a vote
must give the Company at least 60 days advance notice, and that both such
notices must meet certain other requirements. Any shareholder interested in
making such a nomination or proposal should request a copy of such by-law
provisions from the Secretary of Cambrex Corporation.
By Order of the Board of Directors,
PETER E. THAUER,
Secretary
March 23, 1995
UPON WRITTEN REQUEST THE COMPANY WILL PROVIDE TO EACH STOCKHOLDER, WITHOUT
CHARGE, A COPY OF ITS ANNUAL REPORT TO THE SECURITIES AND EXCHANGE COMMISSION ON
FORM 10-K FOR 1994. REQUESTS SHOULD BE DIRECTED TO MR. PETER TRACEY, EXECUTIVE
VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER, CAMBREX CORPORATION, ONE
MEADOWLANDS PLAZA, EAST RUTHERFORD, NJ 07073. SUCH REPORT WILL BE FURNISHED
WITHOUT EXHIBITS. COPIES OF THE EXHIBITS TO SUCH ANNUAL REPORT WILL BE FURNISHED
TO REQUESTING STOCKHOLDERS UPON PAYMENT OF THE COMPANY'S REASONABLE EXPENSES IN
FURNISHING THE SAME.
14
<PAGE> 17
CAMBREX CORPORATION
SOLICITED BY BOARD OF DIRECTORS FOR 1995 ANNUAL MEETING OF STOCKHOLDERS
The undersigned stockholder of CAMBREX CORPORATION, (the "Company") hereby
appoints C.C. Baldwin, Jr., J.A. Mack and P. Tracey, and each of them acting
singly and each with the power of substitution and resubstitution, attorneys
and proxies of the undersigned, with all the powers the undersigned would
possess if personally present, to vote the shares of Common Stock of the
Company which the undersigned is entitled to vote at the 1995 Annual Meeting of
Stockholders of the Company to be on April 27, 1995 at The Plaza Hotel, Fifth
Avenue at Central Park South, New York, New York, and any adjournment thereof.
Without otherwise limiting the general authorization hereby given, said
attorneys and proxies are instructed to vote as indicated on the reverse side
hereof on the proposals set forth in the Notice of Annual Meeting of
Stockholders of the Company and accompanying Proxy Statement, each dated March
23, 1995.
THIS PROXY WILL BE VOTED "FOR" THE ELECTION OF THE 3 NOMINEES FOR DIRECTOR
LISTED IN THE PROXY STATEMENT ACCOMPANYING THE NOTICE OF SAID MEETING (PROPOSAL
NO. 1), AND "FOR" APPROVAL OF THE SELECTION OF ACCOUNTANTS (PROPOSAL NO. 2)
UNLESS OTHERWISE MARKED.
SEE REVERSE
SIDE
PLEASE COMPLETE AND SIGN PROXY ON REVERSE SIDE AND RETURN IN ENCLOSED ENVELOPE.
- -------------------------------------------------------------------------------
/X/ PLEAE MARK YOUR
VOTES AS IN THIS
EXAMPLE.
FOR WITHHOLD
1. ELECTION / / / / NOMINEES: Rosina B. Dixon, M.D.
OF Leon J. Hendrix, Jr.
DIRECTORS Ilan Kaufthal
For, except withheld from the following nominee(s):
- ---------------------------------------------------
FOR AGAINST ABSTAIN
2. Approval of the appointment of Coopers & / / / / / /
Lybrand, L.L.P. as independent public
accountants for 1995.
PLEASE SIGN AND DATE BELOW AND RETURN IN THE ENCLOSED POSTAGE PAID ENVELOPE.
SIGNATURE ________________ DATE _______ SIGNATURE ______________ DATE ________
Note: Please sign exactly as name appears hereon. Joint owners should each
sign. When signing as attorney, executor, administrator, trustee or guardian,
please give full title as such.
